A5075354299- Cardiac pacing and defibrillation studies
- Lipoproteins and Cardiovascular Health
- Cancer Genomics and Diagnostics
- Cardiac Valve Diseases and Treatments
- Cardiac Arrhythmias and Treatments
- Cardiovascular Issues in Pregnancy
- Cardiovascular Function and Risk Factors
- Genetic factors in colorectal cancer
- Neurological Complications and Syndromes
- Renal Transplantation Outcomes and Treatments
- BRCA gene mutations in cancer
University of Utah
2024
University of Miami
2019-2022
Jackson Memorial Hospital
2020-2022
We describe a novel use of evolocumab for successful postoperative lipid control in patient with familial hyperlipidemia who underwent isolated heart transplantation. believe that this case carries valuable lessons regarding post-transplant proprotein convertase subtilisin kexin 9 inhibitor implications the future combined organ allocation and transplantation waitlist times.
Abstract The American College of Medical Genetics and Genomics (ACMG) guidelines for sequence variant classification include two criteria, PP3 BP4, combining computational data with other evidence types contributing to classification. BP4 assert that modeling can provide “Supporting” or against pathogenicity within the ACMG framework. Here, leveraging a meta-analysis ATM CHEK2 breast cancer case-control mutation screening data, we evaluate strength determined from relatively simple tool...
Background: Current guidelines recommend wearable cardioverter-defibrillator (WCD) for primary prevention of sudden cardiac death (SCD) in patients with ischemic cardiomyopathy and ejection fraction (EF) less than 35% if they are within 40 days an event or 90 revascularized. We sought to assess what impact economic factors have on determining which receive a WCD their post-discharge outcomes. Methods: This is single-center, retrospective cohort study investigating outcomes admitted...